Neurocrine Biosciences (NBIX) Retained Earnings: 2010-2021
Historic Retained Earnings for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to -$628.5 million.
- Neurocrine Biosciences' Retained Earnings rose 41.44% to -$628.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$628.5 million, marking a year-over-year increase of 41.44%. This contributed to the annual value of -$725.4 million for FY2020, which is 35.96% up from last year.
- According to the latest figures from Q3 2021, Neurocrine Biosciences' Retained Earnings is -$628.5 million, which was up 3.46% from -$651.0 million recorded in Q2 2021.
- Neurocrine Biosciences' Retained Earnings' 5-year high stood at -$628.5 million during Q3 2021, with a 5-year trough of -$1.3 billion in Q1 2019.
- In the last 3 years, Neurocrine Biosciences' Retained Earnings had a median value of -$1.1 billion in 2020 and averaged -$970.4 million.
- Its Retained Earnings has fluctuated over the past 5 years, first decreased by 22.55% in 2017, then spiked by 41.44% in 2021.
- Neurocrine Biosciences' Retained Earnings (Quarterly) stood at -$1.2 billion in 2017, then climbed by 1.76% to -$1.2 billion in 2018, then increased by 3.83% to -$1.1 billion in 2019, then spiked by 35.96% to -$725.4 million in 2020, then soared by 41.44% to -$628.5 million in 2021.
- Its Retained Earnings was -$628.5 million in Q3 2021, compared to -$651.0 million in Q2 2021 and -$693.3 million in Q1 2021.